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vs. non-LAD lesions (-12.07% vs. -8.07%, p  .0001). The highest ED (-12.05%,
p.001) was in 3.0 mm DES. ED correlated with plaque burden for Endeavor (r 
-0.267, p0.001) and Xience (r  -0.17, p.01), but not Resolute (r  0.006, p0.92).
Conclusions: Actual DES expansion is consistently less than predicted despite high-
pressure deployment. Inter-stent differences and lesion/vessel-specific variables impact
stent performance in vivo. These data have implications on stent selection/deployment
and underscore the value of post-DES intravascular imaging.
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Background: The lesion luminal area after percutaneous treatment, as assessed by
intravascular ultrasound, has demonstrated significant predictive value in the late
follow-up of patients undergoing PCI. The objectives of this analysis were to evaluate the
lesion luminal dimensions of complex coronary bifurcation lesions, as assessed by
intravascular ultrasound, and to correlate such findings with acute and late outcomes.
Methods: Between may 2008 and august 2009, 54 patients with complex bifurcation
lesions, including significant involvement ( 50% stenosis) of both branches and side
branch lesion length extending from its ostium, were randomized for treatment with single
stenting (provisional strategy) (n  27) versus double stenting (n  27).
Results: During procedure, 6 pts allocated for single stenting presented side branch
failure ( 50% residual stenosis, TIMI flow  3 or dissection), given that 5 pts received
an additional stent in the side branch in order to optimize the angiographic result. At final
procedure, the mean minimum lumen area at the side branch ostium (primary endpoint)
were 3.371.62) mm2 in single stenting versus 5.501.41 mm2 in double stenting
(p0.001), according to the randomized allocation. At 9-month angiographic follow-up
at 9 months, the restenosis rates in the side branch were 21.7% in single stenting versus
4% in double stenting (p  0.06), given that all recurrences involved the ostial location.
Considering the treatment received, the side branch restenosis rate was significantly
increase among patients treated with single stenting versus double stenting (27.8% versus
3.3%, p  0.01). The predictors of angiographic restenosis in the side branch included
minimum lumen area in the side branch ostium at final procedure (p  0.03).
Conclusions: These results suggest that final luminal dimensions at the side branch
ostium may be impact late outcomes of complex bifurcation lesions undergoing
percutaneous treatment. Thus, complex coronary bifurcation lesions may benefit from a
primary percutaneous approach with double stenting strategy, given that most such benefit
was associated with a larger lumen area obtained at the side branch ostium.
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Background: Optical coherence tomography (OCT) can provide detailed informations
after stent implantation with a 10 fold better resolution than IVUS. Otherwise, intravas-
cular ultrasound guidance (IVUS) is useful in stenting, particularly in case of unprotected
left main coronary artery stenosis. This study aimed to compare OCT to IVUS
performance to assess immediate results after left main percutaneous coronary interven-
tion (PCI) and to detect complications after left main stenting.
Methods: Patients with unprotected left main stenosis refered for PCI because of high
risk surgery or low syntax score were included at our centre. T provisional stenting with
last generation drug eluting stent was the predefined planned strategy. OCT and IVUS
analysis were performed immediately after PCI for each patients in the main branch.
Additional procedures (balloon inflation, second stent) was left at the discretion of the
operator, depending of OCT and IVUS results. Images from OCT and IVUS were
analyzed by 2 operators to look at stent expansion, stent apposition and vessel dissection.
Results: 15 patients were finally included. OCT and IVUS was successfully performed
without any specific complication. A stent underexpansion was found in 3 patients and no
difference between IVUS and OCT efficiency was found for this criteria. For one patient,
a vessel dissection at the distal edge of the stent was observed by OCT but not by IVUS.
Concerning stent apposition, a circumferential stent malapposition was found in 4 patients
by OCT at the proximal part of the stent and was not seen by IVUS. Local malappositions
were also found in 3 patients by OCT compared to only one confirmed by IVUS.
Conclusions: This pilot study for the use of OCT in left main stenting showed that this
technique is highly feasible in this situation. Our results suggest that OCT may be more
accurate than IVUS for dissection and malapposition diagnosis.
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Background: Though efficacy of everolimus-eluting stent (EES; Xience V) is well-
established by many clinical evidences, several trials failed to show superiority in diabetic
subset. We hypothesized that inappropriate stent expansion in complex lesion of diabetes
due to thin cobalt chromium platform may be one of the reasons. The purpose of this study
is to investigate this hypothesis using intravascular ultrasound (IVUS).
Methods: 183 de novo lesions (62 EES, 69 paclitaxel-eluting stent (PES; Taxus
Express2, thick stainless platform) and 52 biolimus-eluting stent (BES; Nobori, thick
stainless platform with open cell design)) treated by elective IVUS-guided PCI for stable
patients were recruited in this study. Stent size was determined according to pre-
procedural IVUS findings. After stent deployment, IVUS procedure was repeated and
stent diameter and cross-sectional area (CSA) were measured. If stent expansion was
inadequate, post dilation was performed using short-length high pressure balloon and
again IVUS was performed. IVUS findings were then compared with estimated diameter
and CSA calculated from each stent compliance chart.
Results: In EES, there were significant differences of stent expansion and symmetry
index between diabetic and non-diabetic just after stenting. These differences were not
observed in thick stainless platform PES and BES though stent designs were different
between two stents. According to IVUS, 68% of diabetic cases in EES group required post
balloon dilatation to obtain optimal stent expansion. After post dilatation, difference
between diabetic and non-diabetic disappeared in EES.
Conclusions: In EES, asymmetrical stent underexpansion was observed in diabetic
patient after stent deployment, however, IVUS-guided post-dilatation overcome this
disadvantage. IVUS-guided EES implantation can improve clinical outcome in patients
with diabetes.
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0.715 0.776 0.002 0.757 0.776 0.34 0.800 0.817 0.38
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CSA(mm2)
0.633 0.700 0.019 0.680 0.722 0.13 0.744 0.758 0.64
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0.802 0.855 0.007 0.842 0.835 0.72 0.856 0.876 0.24
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